1 / 21

Female Condom Consortium

Reproductive Health Supplies Coalition SEMI-ANNUAL MEMBERSHIP MEETING. Female Condom Consortium. Presentation by Yvonne Bogaarts World Population Foundation 25 October 2007. Structure. State of the Art Acceptibility Obstacles Potential of female condom Consortium: partners & plans R&D

bronwynj
Download Presentation

Female Condom Consortium

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Reproductive Health Supplies CoalitionSEMI-ANNUAL MEMBERSHIP MEETING Female Condom Consortium Presentation by Yvonne Bogaarts World Population Foundation 25 October 2007

  2. Structure • State of the Art • Acceptibility • Obstacles • Potential of female condom • Consortium: partners & plans • R&D • Implementation in selected countries • Knowledge centre • Difference the RHSC can make

  3. Female condom products • Female Health Company in USA: FC 1 (poly-urethane) (approved by USFDA, 1993) • FC 2 (nitrile) (approved by WHO 2006)

  4. Medtech Health Products in India: V’Amour FC/Dr. Reddy (latex) (approved by India Drug Controller in 2003, not approved by WHO)

  5. Forthcoming PATH: development of a better product Timing: will take another 2-3 years

  6. Female Health Company • US based company • Introduction 1992, approved USFDA in 1993 • Production started in 1996 • In 2007: sole manufacturer for donor and UN agencies • Production increased 10x times since 1996 • Production in 2005: 22 million female condoms (12 million for developing countries) • Available in 108 countries

  7. Buyers of the female condom In 2004 • 2,3 million by UNFPA • 2 million bought by USAID • 1,6 million by DFID • Rest donors: KfW and DANIDA • Governments of Brazil, South Africa, Zimbabwe, France, Kenya • Private sector/NGO: PSI, DKT, IPPF and MSI • Private sector/ shops (P. Friel, 2005)

  8. Global consultations • 1993 “Potential Role of the Female Condom in International AIDS Prevention”, AIDSCAP • 1997 “The Female Condom: From Research to Marketplace” AIDSCAP • 2001 “Technical Update on the Female Condom” FHI • 2004 Expert meeting on female condom GCM/GCWA • 2005 Global Consultation on Female Condoms (Baltimore)

  9. Same barriers discussed - stereotypes on women and sexuality - pre-conceived ideas - costs - lack of funding and funders - provider resistance

  10. Acceptibility • No static fact • Studies indicate high acceptability rate • Acceptability influenced by: - individual factors – insertion skills and practice - male partners - environment

  11. Potential of female condom Female Condom is: + effective contraceptive + protects against STIs, including HIV + women-initiated + available NOW = a real addition to method mix

  12. Potential of female condom Female condom important in context of: • high maternal mortality rate • feminisation of HIV/AIDS • limited choice infection-prevention methods • high cost and limited availability AIDS treatment

  13. Female Condom Consortium:Tackle the Challenges Five partners: - Oxfam Novib - World Population Foundation - Dutch Ministry of Foreign Affairs - JIPPY Foundation - IDA Solutions

  14. Plans Female Condom Consortium R&D: cheaper female condom Country programme Knowledge centre

  15. Research & Development • Female Condom Consortium: development of cheaper product • Latex Timing • FCC: May 2008 to be on the market Quality assurance: international (WHO)

  16. Country programme • Nigeria: 3 selected states • Malawi National Advisory Board set up Main actors: • Civil society: IEC, distribution • Government and UN: advocacy, support IEC and distribution, financing • Private sector: subsidised distribution and promotion, sale at affordable price

  17. Country programme Main areas: • Registration: national (NAFDAC) • Procurement, Logistics, Importation, Distribution • Marketing and Sales • Monitoring & Evaluation

  18. Knowledge centre • Data base • Disseminate results country implementation • Advocacy • Enhance collaboration and cooperation Working for professionals in the field, donor community and policymakers

  19. What difference RHSC make? • Positive Advocacy for the female condom, not ridicule it! • Support ongoing and further R&D • Funding

  20. Thank you!Questions, remarks, comments: y.bogaarts@wpf.org

More Related